Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis
- PMID: 34516348
- PMCID: PMC8806527
- DOI: 10.1080/21655979.2021.1975980
Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis
Abstract
Glioblastoma multiforme (GBM) is the most common primary intracranial malignancy in adults. Owing to individual tolerance and tumor heterogeneity, the therapy methods for young adults do not apply to older adults. The present study aimed to identify specific biomarkers for GBM in older adults using weighted gene co-expression network analysis (WGCNA). Gene expression profiles of older adults with GBM were downloaded from The Cancer Genome Atlas (TCGA) and set as a discovery cohort to construct WGCNA. Core genes of clinically significant modules were used to perform functional enrichment, protein-protein interaction, and Pearson correlation analyses. Gene expression profiles of young in TCGA and older GBM patients from our research group were set as verification cohorts for hub gene expression and diagnostic value. Four significant gene modules associated clinically with older adults with GBM were identified, whereas 251 genes were core genes with module membership>0.8 and gene significance>0.2. Ermin (ERMN), myelin-associated oligodendrocyte basic protein (MOBP), proteolipid protein 1 (PLP1), and oligodendrocytic myelin paranodal and inner loop protein (OPALIN) genes had significant relationships with the Karnofsky score (KPS) in older GBM patients. ERMN, MOBP, PLP1, and OPALIN had no relationship with KPS in young GBM patients. These genes were upregulated in GBM tissues from older patients with low but not high KPS and had high diagnostic value. In conclusion, ERMN, MOBP, PLP1, and OPALIN may serve as specific biomarkers for the progression of GBM in older adults.
Keywords: Glioblastoma; WGCNA; biomarkers; elder.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.Bioengineered. 2021 Dec;12(1):3188-3200. doi: 10.1080/21655979.2021.1943986. Bioengineered. 2021. PMID: 34238116 Free PMC article.
-
Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.J Cell Mol Med. 2021 Feb;25(3):1633-1644. doi: 10.1111/jcmm.16264. Epub 2021 Jan 15. J Cell Mol Med. 2021. PMID: 33449451 Free PMC article.
-
Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.Mol Med Rep. 2020 Aug;22(2):859-869. doi: 10.3892/mmr.2020.11160. Epub 2020 May 20. Mol Med Rep. 2020. PMID: 32467990 Free PMC article.
-
An update on the epigenetics of glioblastomas.Epigenomics. 2016 Sep;8(9):1289-305. doi: 10.2217/epi-2016-0040. Epub 2016 Sep 2. Epigenomics. 2016. PMID: 27585647 Review.
-
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.Int J Mol Sci. 2024 Mar 6;25(5):3040. doi: 10.3390/ijms25053040. Int J Mol Sci. 2024. PMID: 38474286 Free PMC article. Review.
Cited by
-
Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods.BioData Min. 2023 Sep 26;16(1):26. doi: 10.1186/s13040-023-00341-1. BioData Min. 2023. PMID: 37752578 Free PMC article.
-
Peritumoral Brain Zone in Astrocytoma: Morphology, Molecular Aspects, and Clinical Manifestations (Review).Sovrem Tekhnologii Med. 2024;16(2):79-88. doi: 10.17691/stm2024.16.2.08. Epub 2024 Apr 27. Sovrem Tekhnologii Med. 2024. PMID: 39539752 Free PMC article. Review.
-
Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.PLoS One. 2023 Dec 21;18(12):e0295699. doi: 10.1371/journal.pone.0295699. eCollection 2023. PLoS One. 2023. PMID: 38127902 Free PMC article.
-
Nucleotide-Binding Oligomerization Domain (NOD)-Like Receptor Subfamily C (NLRC) as a Prognostic Biomarker for Glioblastoma Multiforme Linked to Tumor Microenvironment: A Bioinformatics, Immunohistochemistry, and Machine Learning-Based Study.J Inflamm Res. 2023 Feb 10;16:523-537. doi: 10.2147/JIR.S397305. eCollection 2023. J Inflamm Res. 2023. PMID: 36798872 Free PMC article.
-
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.Oncol Lett. 2024 Mar 13;27(5):206. doi: 10.3892/ol.2024.14339. eCollection 2024 May. Oncol Lett. 2024. PMID: 38516683 Free PMC article.
References
-
- Lah TT, Novak M, Breznik B.. Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262–273. - PubMed
-
- Laigle-Donadey F. [Glioblastoma in the elderly]. Geriatr Psychol Neuropsychiatr Vieil. 2019;17:173–178. - PubMed
-
- Iskandar AS, Kerr WT, Hwang A, et al. Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: a single-institution retrospective cohort study. J Oncol Pharm Pract. 2019;25(8):1999–2003. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials